Braskem (NYSE:BAK – Get Free Report) is expected to announce its Q1 2025 earnings results before the market opens on Thursday, May 8th. Analysts expect Braskem to post earnings of $0.06 per share and revenue of $22.86 billion for the quarter.
Braskem (NYSE:BAK – Get Free Report) last posted its quarterly earnings results on Thursday, February 27th. The company reported ($0.39) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.38) by ($0.01). Braskem had a negative net margin of 9.88% and a negative return on equity of 439.59%. The business had revenue of $3.28 billion for the quarter, compared to analysts’ expectations of $3.52 billion. On average, analysts expect Braskem to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Braskem Trading Up 3.5 %
NYSE BAK opened at $3.66 on Wednesday. Braskem has a 1-year low of $2.85 and a 1-year high of $8.09. The stock has a 50-day moving average of $3.63 and a 200-day moving average of $4.38. The firm has a market cap of $1.46 billion, a PE ratio of -1.03 and a beta of 1.83.
Analysts Set New Price Targets
Read Our Latest Stock Report on BAK
Braskem Company Profile
Braskem SA, together with its subsidiaries, produces and sells thermoplastic resins. The company operates through three segments: Brazil, United States and Europe, and Mexico. The Brazil segment produces and sells olefins, including ethylene, polymer and chemical grade propylene, butadiene, and butene-1; benzene, toluene, and xylenes products; fuels, such as automotive gasoline, liquefied petroleum gas, ethyl tertiary-butyl ether, and methyl tertiary-butyl ether; intermediates, such as cumene; aliphatics, aromatics, and hydrogenated solvents; and specialties comprising isoprene, dicyclopentadiene, piperylene, nonene, tetramer, polyisobutylene, and hydrocarbon resins.
Featured Stories
- Five stocks we like better than Braskem
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- 3 Mid-Cap Medical Stocks Outperforming the Market
- High Flyers: 3 Natural Gas Stocks for March 2022
- The Top-Ranked Insider Buys From April by Market Cap
- How to Read Stock Charts for Beginners
- Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
Receive News & Ratings for Braskem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Braskem and related companies with MarketBeat.com's FREE daily email newsletter.